Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?

References

• Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm Sci 2004;284:109–122
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Poor aqueous solubility: an industry wide problem in drug discovery. Am Pharma Rev 2002;5:82–85
   Google Scholar
• Singh SK, Srinivasan K, Gowthamarajan K, et al. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur J Pharm Biopharm 2011;78:441–446
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Inkyo M, Yumoto R, et al. Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption. Drug Dev Ind Pharm 2012;38:1015–1023
   PubMed Web of Science ®Google Scholar
• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–934
   Google Scholar
• Afolabi A, Akinlabi O, Bilgili E. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view. Eur J Pharm Sci 2014;51:75–86
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing – oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631–644
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 2008;36:43–48
   PubMed Web of Science ®Google Scholar
• Monteiro A, Afolabi A, Bilgili E. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect. Drug Dev Ind Pharm 2013;39:266–283
   PubMed Web of Science ®Google Scholar
• Müller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliver Rev 2001;47:3–19
   PubMed Web of Science ®Google Scholar
• Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. preparation by a size-reduction technique. Int J Pharm 1998;160:229–237
   Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–796
   PubMed Web of Science ®Google Scholar
• Cooper ER. Nanoparticles: a personal experience for formulating poorly water soluble drugs. J Control Release 2010;141:300–302
   PubMed Web of Science ®Google Scholar
• Basa S, Muniyappan T, Karatgi P, et al. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Dev Ind Pharm 2008;34:1209–1218
   PubMed Web of Science ®Google Scholar
• Bhakay A, Davé R, Bilgili E. Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating. Powder Technol 2013;236:221–234
   Web of Science ®Google Scholar
• Bhakay A, Azad M, Vizzotti E, et al. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants. Drug Dev Ind Pharm 2014;40:1509–1522
   PubMed Web of Science ®Google Scholar
• Lee J. Drug nano- and microparticles processed into solid dosage forms: physical properties. J Pharm Sci 2003;92:2057–2068
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008;364:64–75
   PubMed Web of Science ®Google Scholar
• Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications. Int J Pharm 2012;423:496–508
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm 2010;396:210–218
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 2011;63:456–469
   PubMed Web of Science ®Google Scholar
• Bilgili E, Afolabi A. A combined microhydrodynamics–polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. Int J Pharm 2012;439:193–206
   PubMed Web of Science ®Google Scholar
• Knieke C, Azad M, Davé R, Bilgili E. A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves. Chem Eng Res Des 2013;91:1245–1258
   Web of Science ®Google Scholar
• Napper DH. Colloid stability. Ind Eng Chem Prod Res Dev 1970;9:467–477
   Web of Science ®Google Scholar
• Meng X, Yang D, Keyvan G, et al. Synthesis and immobilization of micro-scale drug particles in presence of β-cyclodextrins. Colloid Surf B 2012;92:213–222
   PubMed Web of Science ®Google Scholar
• Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm 2011;406:145–152
   PubMed Web of Science ®Google Scholar
• Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm 2008;355:328–336
   PubMed Web of Science ®Google Scholar
• Lee J, Lee S-J, Choi J-Y, et al. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci 2005;24:441–449
   PubMed Web of Science ®Google Scholar
• Choi J-Y, Yoo JY, Kwak H-S, et al. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys 2005;5:472–474
   Web of Science ®Google Scholar
• George M, Ghosh I. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci 2013;48:142–152
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Vermant J, Martens JA, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci 2009;98:2091–2103
   PubMed Web of Science ®Google Scholar
• Bruno JA, Doty BD, Gustow E, et al. Method of grinding pharmaceutical substances. US Patent No. 07/981639; 1996
   Google Scholar
• Verma S, Huey BD, Burgess DJ. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir 2009;25:12481–12487
   PubMed Web of Science ®Google Scholar
• Bhakay A, Merwade M, Bilgili E, Dave RN. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs. Drug Dev Ind Pharm 2011;37:963–976
   PubMed Web of Science ®Google Scholar
• Opoczky L, Farnady F. Fine grinding and states of equilibrium. Powder Technol 1984;39:107–115
   Web of Science ®Google Scholar
• Panmai S, Deshpande S. Development of nanoformulations: selection of polymeric stabilizers based on adsorption isotherm. PMSE Preprints 2003;89:808–809
   Google Scholar
• Ryde NP, Ruddy SB. Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate. US Patent No. 6375986; 2002
   Google Scholar
• Gupta RB, Kompella UB. Nanoparticle technology for drug delivery. New York: Taylor & Francis; 2006:244–252
   Google Scholar
• Zhu W, Romanski FS, Dalvi SV, et al. Atomistic simulations of aqueous griseofulvin crystals in the presence of individual and multiple additives. Chem Eng Sci 2012;73:218–230
   Web of Science ®Google Scholar
• Bilgili E, Hamey R, Scarlett B. Production of pigment nanoparticles using a wet stirred mill with polymeric media. China Particuology 2004;2:93–100
   Google Scholar
• Bilgili E, Hamey R, Scarlett B. Nano-milling of pigment agglomerates using a wet stirred media mill: elucidation of the kinetics and breakage mechanisms. Chem Eng Sci 2006;61:149–157
   Web of Science ®Google Scholar
• Sommer M, Stenger F, Peukert W, Wagner NJ. Agglomeration and breakage of nanoparticles in stirred media mills – a comparison of different methods and models. Chem Eng Sci 2006;61:135–148
   Web of Science ®Google Scholar
• Kissa E. Dispersions: characterization, testing, and measurement. Boca Raton: CRC Press; 1999
   Google Scholar
• Jamzad S, Fassihi R. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide – a technical note. AAPS PharmSciTech 2006;7:E17–E22
   PubMed Web of Science ®Google Scholar
• Ng JD, Lorber B, Witz J, et al. The crystallization of biological macromolecules from precipitates: evidence for Ostwald ripening. J Cryst Growth 1996;168:50–62
   Web of Science ®Google Scholar
• Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 2011;409:260–268
   PubMed Web of Science ®Google Scholar
• Berglund KD, Przybycien TM, Tilton RD. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 1. Role of polymer hydrophobic modification. Langmuir 2003;19:2705–2713
   Web of Science ®Google Scholar
• Evertsson H, Nilsson S. Microviscosity in clusters of ethyl hydroxyethyl cellulose and sodium dodecyl sulfate formed in dilute aqueous solutions as determined with fluorescence probe techniques. Macromolecules 1997;30:2377–2385
   Web of Science ®Google Scholar
• Winnik FM, Winnik MA. The interaction of sodium dodecylsulfate with (hydroxypropyl) cellulose. Polym J 1990;22:482–488
   Web of Science ®Google Scholar
• Mishra PR, Shaal LA, Müller RH, Keck CM. Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int J Pharm 2009;371:182–189
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm 2013;443:209–220
   PubMed Web of Science ®Google Scholar
• Plakkot S, de Matas M, York P, et al. Comminution of ibuprofen to produce nano-particles for rapid dissolution. Int J Pharm 2011;415:307–314
   PubMed Web of Science ®Google Scholar
• Sharma P, Denny WA, Garg S. Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm 2009;380:40–48
   PubMed Web of Science ®Google Scholar
• Verheezen JJAM, Maarschalk KV, Faassen F, Vromans H. Milling of agglomerates in an impact mill. Int J Pharm 2004;278:165–172
   PubMed Web of Science ®Google Scholar
• Smith PG. A study of fluidised bed granulation. PhD Thesis. The University of London; 1980
   Google Scholar
• Sahoo A, Sahoo L. Studies on parameter estimation for particle growth in a fluidized bed granulator: interval halving method. Int J Eng Res 2014;3:182–185
   Google Scholar
• Knieke C, Azad M, To T, et al. Sub-100 micron fast dissolving nanocomposite drug powders. Powder Technol 2015;271:49–60
   Web of Science ®Google Scholar